XML 60 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
11. Segment Information (Tables)
 9 Months Ended
Sep. 30, 2012
Segment Reporting [Abstract]  
Information regarding industry segments
Information regarding industry segments for the three months ended September 30, 2012 and 2011 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2012
$
167.0

 
$
328.4

 
$
3.3

 
2011
$
171.5

 
$
341.3

 
$
3.7

 
 
 
 
 
 
 
Segment profit
2012
$
6.4

 
$
47.0

 
$
—

 
2011
$
12.5

 
$
49.5

 
$
0.5


Information regarding industry segments for the nine months ended September 30, 2012 and 2011 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2012
$
484.2

 
$
999.6

 
$
11.6

 
2011
$
495.9

 
$
1,016.5

 
$
10.9

 
 
 
 
 
 
 
Segment profit
2012
$
7.8

 
$
148.1

 
$
1.9

 
2011
$
25.6

 
$
144.1

 
$
1.1
Reconciliation of segment profit to consolidated income before taxes
The following reconciles total segment profit to consolidated income before taxes (in millions):

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2012
 
2011
 
2012
 
2011
Total segment profit
$
53.4

 
$
62.5

 
$
157.8

 
$
170.9

Foreign exchange losses, net
(0.4
)
 
(6.3
)
 
(3.5
)
 
(12.1
)
Net corporate operating, interest and other expense not allocated to segments
(1.1
)
 
(0.9
)
 
(3.4
)
 
(2.8
)
Other income (expense), net
1.5

 
0.5

 
14.7

 
5.9

Consolidated income before taxes
$
53.4

 
$
55.8

 
$
165.6

 
$
161.9